| Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis EC Rizos, EE Ntzani, E Bika, MS Kostapanos, MS Elisaf Jama 308 (10), 1024-1033, 2012 | 1370 | 2012 |
| Components of the metabolic syndrome and risk for first-ever acute ischemic nonembolic stroke in elderly subjects HJ Milionis, E Rizos, J Goudevenos, K Seferiadis, DP Mikhailidis, ... Stroke 36 (7), 1372-1376, 2005 | 202 | 2005 |
| Metformin does not affect cancer risk: a cohort study in the UK Clinical Practice Research Datalink analyzed like an intention-to-treat trial KK Tsilidis, D Capothanassi, NE Allen, EC Rizos, DS Lopez, ... Diabetes care 37 (9), 2522-2532, 2014 | 197 | 2014 |
| Mechanisms of hyponatraemia in alcohol patients GL Liamis, HJ Milionis, EC Rizos, KC Siamopoulos, MS Elisaf Alcohol and Alcoholism 35 (6), 612-616, 2000 | 119 | 2000 |
| Type 2 diabetes and cancer: an umbrella review of observational and mendelian randomization studies J Pearson-Stuttard, N Papadimitriou, G Markozannes, S Cividini, ... Cancer Epidemiology, Biomarkers & Prevention 30 (6), 1218-1228, 2021 | 118 | 2021 |
| The combination of nebivolol plus pravastatin is associated with a more beneficial metabolic profile compared to that of atenolol plus pravastatin in hypertensive patients with … E Rizos, E Bairaktari, A Kostoula, G Hasiotis, A Achimastos, E Ganotakis, ... Journal of cardiovascular pharmacology and therapeutics 8 (2), 127-134, 2003 | 108 | 2003 |
| Treating to target patients with primary hyperlipidaemia: comparison of the effects of ATOrvastatin and ROSuvastatin (the ATOROS study) HJ Milionis, E Rizos, M Kostapanos, TD Filippatos, IF Gazi, ES Ganotakis, ... Current medical research and opinion 22 (6), 1123-1131, 2006 | 106 | 2006 |
| The effect of statin therapy on arterial stiffness by measuring pulse wave velocity: a systematic review E C Rizos, A P Agouridis, M S Elisaf Current vascular pharmacology 8 (5), 638-644, 2010 | 97 | 2010 |
| Are high density lipoprotein (HDL) and triglyceride levels relevant in stroke prevention? E Rizos, DP Mikhailidis Cardiovascular research 52 (2), 199-207, 2001 | 79 | 2001 |
| Lipoprotein-associated PAF-acetylhydrolase activity in subjects with the metabolic syndrome E Rizos, AP Tambaki, I Gazi, AD Tselepis, M Elisaf Prostaglandins, leukotrienes and essential fatty acids 72 (3), 203-209, 2005 | 76 | 2005 |
| Genetic effects versus bias for candidate polymorphisms in myocardial infarction: case study and overview of large-scale evidence EE Ntzani, EC Rizos, JPA Ioannidis American journal of epidemiology 165 (9), 973-984, 2007 | 75 | 2007 |
| Smoking diminishes the beneficial effect of statins: observations from the landmark trials HJ Milionis, E Rizos, DP Mikhailidis angiology 52 (9), 575-587, 2001 | 69 | 2001 |
| Effect of ciprofibrate on C-reactive protein and fibrinogen levels E Rizos, A Kostoula, M Elisaf, DP Mikhailidis Angiology 53 (3), 273-277, 2002 | 62 | 2002 |
| Effect of ciprofibrate on lipoproteins, fibrinogen, renal function, and hepatic enzymes E Rizos, E Bairaktari, E Ganotakis, V Tsimihodimos, DP Mikhailidis, ... Journal of cardiovascular pharmacology and therapeutics 7 (4), 219-226, 2002 | 60 | 2002 |
| Educational strategies to train health care professionals across the education continuum on the process of frailty prevention and frailty management: a systematic review T Windhaber, ML Koula, E Ntzani, A Velivasi, E Rizos, MT Doumas, ... Aging clinical and experimental research 30, 1409-1415, 2018 | 57 | 2018 |
| Non-Hodgkin’s Lymphomas in Greece according to the WHO Classification of Lymphoid NeoplasmsA Retrospective Analysis of 810 Cases T Economopoulos, S Papageorgiou, MA Dimopoulos, N Pavlidis, ... Acta haematologica 113 (2), 97-103, 2005 | 57 | 2005 |
| Are high-density lipoprotein and triglyceride levels important in secondary prevention: impressions from the BIP and VA-HIT trials E Rizos, DP Mikhailidis International journal of cardiology 82 (3), 199-207, 2002 | 57 | 2002 |
| Statin therapy with or without ezetimibe and the progression to diabetes F Barkas, M Elisaf, E Liberopoulos, E Klouras, G Liamis, EC Rizos Journal of Clinical Lipidology 10 (2), 306-313, 2016 | 52 | 2016 |
| Does supplementation with omega-3 PUFAs add to the prevention of cardiovascular disease? EC Rizos, MS Elisaf Current Cardiology Reports 19, 1-8, 2017 | 51 | 2017 |
| Prediabetes: to treat or not to treat? E Moutzouri, V Tsimihodimos, E Rizos, M Elisaf European journal of pharmacology 672 (1-3), 9-19, 2011 | 46 | 2011 |
